Stockholders’ Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Feb. 02, 2026	Dec. 31, 2025
Stockholders’ Equity (Details) [Line Items]
Share repurchase program, authorized, amount			$ 75,000
Treasury stock, shares, acquired (in shares)	1,600,000
Treasury stock, value, acquired, cost method	$ 11,092
Preferred stock, shares authorized (in shares)	2,000,000			2,000,000
Preferred stock, par value (in dollars per share)	$ 0.001			$ 0.001
Period of unrecognized compensation expense (in years)	10 months 24 days
Shares underlying restricted stock units
Stockholders’ Equity (Details) [Line Items]
Granted (in shares)	2,622,062			1,274,750
Weighted average grant date fair value (in dollars per share)	$ 7.26	$ 10.21
Number of shares issued (in shares)	464,554	487,500
Outstanding RSUs and PSU (in shares)	4,408,928
Unrecognized compensation expense	$ 33,700
Period of unrecognized compensation expense (in years)	1 year 10 months 24 days
Share-Based Payment Arrangement, Option
Stockholders’ Equity (Details) [Line Items]
Unrecognized compensation expense	$ 1,700
Board of Directors
Stockholders’ Equity (Details) [Line Items]
Preferred stock, shares authorized (in shares)	2,000,000
Executive Officers | Shares underlying restricted stock units
Stockholders’ Equity (Details) [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 10.38	$ 11.79